Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jul-Aug;93(7-8):1847-1853.
doi: 10.1111/ans.18482. Epub 2023 Apr 20.

Survival outcomes for patients with colorectal cancer with synchronous liver only metastasis

Affiliations

Survival outcomes for patients with colorectal cancer with synchronous liver only metastasis

Mia Shepherdson et al. ANZ J Surg. 2023 Jul-Aug.

Abstract

Background: Colorectal cancer with synchronous liver-only metastasis is managed with a multimodal approach, however, optimal sequencing of modalities remains unclear.

Methods: A retrospective review of all consecutive rectal or colon cancer cases with synchronous liver-only metastasis was conducted from the South Australian Colorectal Cancer Registry from 2006 to 2021. This study aimed to investigate how order and type of treatment modality affects overall survival.

Results: Data of over 5000 cases were analysed (n = 5244), 1420 cases had liver-only metastasis. There were a greater number of colon than rectal primaries (N = 1056 versus 364). Colonic resection was the preferred initial treatment for the colon cohort (60%). In the rectal cohort, 30% had upfront resection followed by 27% that had chemo-radiotherapy as 1st line therapy. For the colon cohort, there was an improved 5-year survival with surgical resection as initial treatment compared to chemotherapy (25% versus 9%, P < 0.001). In the rectal cohort, chemo-radiotherapy as the initial treatment was associated with an improved 5-year survival compared to surgery or chemotherapy (40% versus 26% versus 19%, P = 0.0015). Patients who were able to have liver resection had improved survival, with 50% surviving over 5 years compared to 12 months in the non-resected group (P < 0.001). Primary rectal KRAS wildtype patients who underwent liver resection and received Cetuximab had significantly worse outcomes compared to KRAS wildtype patients who did not (P = 0.0007).

Conclusions: Where surgery is possible, resection of liver metastasis and primary tumour improved overall survival. Further research is required on the use of targeted treatments in patients undergoing liver resection.

Keywords: colorectal; liver; metastasis; survival.

PubMed Disclaimer

References

    1. Roy AC, Karapetis CS, Piantadosi C et al. Patterns of care for synchronous rectal cancer with liver-only metastasis: results from the South Australian registry of metastatic colorectal cancer. J. Clin. Oncol. 2017; 35: 701.
    1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 2018; 68: 394-424.
    1. Engstrand J, Nilsson H, Strömberg C, Jonas E, Freedman J. Colorectal cancer liver metastases: a population-based study on incidence, management and survival. BMC Cancer 2018; 18: 78.
    1. Australian Institute of Health and Welfare. Colorectal and other digestive-tractcancers. 2018; Cancer series no. 114.
    1. Wang XY, Chang WJ, Xu JM. Synchronous robotic resection for colorectal liver metastasis. Zhonghua Wei Chang Wai Ke Za Zhi 2020; 23: 1139-43.

Substances

LinkOut - more resources